P. gingivalis virulence factors correlate with disease activity in periodontitis and rheumatoid arthritis

Both periodontitis and rheumatoid arthritis (RA) are chronic inflammatory conditions, with growing evidence suggesting a shared pathogenic link. Porphyromonas gingivalis (P. gingivalis), a key bacterium in periodontal disease, has been implicated in exacerbating systemic inflammation, including RA. Its virulence factors, such as gingipains and peptidylarginine-deiminase (PAD) enzymes, are thought to contribute to this link by promoting inflammation and citrullination, a process central to RA autoimmunity. Understanding the specific virulence factors involved could reveal novel therapeutic targets for managing both diseases.

This comparative study investigated the prevalence and impact of P. gingivalis virulence factors in patients with RA (n=22), RA plus periodontitis (n=22), periodontitis (n=10), and healthy controls (n=35). Researchers compared groups for systemic inflammatory markers like C-reactive protein and anti-cyclic citrullinated peptide IgG, as well as peptidylarginine-deiminase (PAD)2/4 activity and anti-P. gingivalis virulence-associated gingipain antibodies. For periodontitis patients, colony-forming units of P. gingivalis, Tannerella forsythia, and Prevotella intermedia were quantified, alongside gene variants of P. gingivalis including PAD (P.PAD), major fimbriae (fimA), lysine-gingipain (kgp), and receptor antigen gene B (ragB).

The study identified significant associations between specific P. gingivalis virulence factors and disease severity. A higher mean clinical periodontal attachment loss was observed in patients carrying P.PAD type 1 gene variants (p=0.033). Furthermore, the major fimbriae (fimA) and lysine-gingipain (kgp) gene variants exhibited distinct distributions across the different patient groups, suggesting their differential roles in disease manifestation. Crucially, circulating anti-gingipain IgG levels showed a positive correlation with RA disease activity, indicating a systemic immune response linked to bacterial virulence. This suggests that the immune system's recognition of P. gingivalis gingipains may directly contribute to the inflammatory burden in RA patients. The findings underscore the complex interplay between oral microbiota and systemic autoimmune conditions. While specific fold-changes for gene variants or antibody levels were not detailed in the abstract, the statistical significance of P.PAD type 1 and the correlation with RA activity are key. The study's total n=89 provides a robust comparative dataset. > Anti-gingipain IgG levels showed positive correlations with RA disease activity, highlighting a potential pathogenic link between oral infection and systemic autoimmunity.